Invitrogen™ Human JAM-A/CD321/F11R ELISA Kit

Ref.: BL-RE-091612Manufacturer ref.: EH283RBX10 10 x 96 tests
€4,995.00 excl. VAT

Human JAM-A/CD321/F11R quantitates human JAM-A/CD321/F11R in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human JAM-A/CD321/F11R.

Accession number
9130004G24 ; AA638916 ; antigène BV11 ; CD321 ; ESTM33 ; F11 R ; récepteur F11 ; récepteur F11/F11R ; F11r ; JAM ; Jam1 ; JAM-1 ; JAMA ; JAM-A ; Jcam ; Jcam1 ; molécule d’adhésion de cellules de jonction A ; molécule d’adhésion de cellules de jonction1 ; molécule d’adhésion de cellules jonctionnelle 1 ; molécule d’adhésion de cellules jonctionnelle A ; KAT ; Ly106 ; PAM-1 ; molécule d’adhésion de plaquettes 1 ; récepteur de plaquettes F11 ; UNQ264/PRO301
Dose range
13 to 10.000 pg/ml
Sensitivity of the dosage
13 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human JAM-A/CD321/F11R quantitates human JAM-A/CD321/F11R in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human JAM-A/CD321/F11R.

Human JAM-A/CD321/F11R quantitates human JAM-A/CD321/F11R in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human JAM-A/CD321/F11R.

CD321 (F11R, JAM-1, JAM-A) is a cell surface adhesion molecule that belongs to the Ig receptor superfamily. CD321 is a 32-41 kD glycoprotein with two extracellular Ig-like domains, a transmembrane region, and a short cytosolic tail. The protein sassembly at the membrane level as a homodimer and may be associated laterally with other membrane proteins, including integrins. CD321 is expressed on various types of cells, including leukocytes, platelets, erythrocytes, stem cells, epithelial and endothelial cells, and plays a role in cell-cell contact mediation. CD321 is located in the immediate vicinity of several components of tight epithelial junctions, including ZO-1 and l-occludine. CD321 is involved in maintaining epithelial and endothelial barriers, haematopoiesis, angiogenesis and tumour proliferation, invasion and metastasis.

Sensitivity

Sensitivity of the dosage: 13 pg/ml.

Measurement range

Dose range: 13 to 10,000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: JAM-A (CD321).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17834110
Specifications
Accession number9130004G24; AA638916; BV11 antigen; CD321; ESTM33; F11 R; receiver F11; receiver F11/F11R; F11r; JAM; Jam1; JAM-1; JAMA; JAM-A; Jcam; Jcam1; junction cell adhesion molecule A; junction cell adhesion molecule1; junction cell adhesion molecule
Dose range13 to 10.000 pg/ml
Sensitivity of the dosage13 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q9Y624
Gene symbol(s)F11r
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusUse exclusively for research
TargetJAM-A (CD321)
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 μl; Serum, 50 μl; Plasma, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH283RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.